Tuesday, September 25, 2018 12:33:37 PM
"Warrants NEVER have a positive value for the party that sold them. If they did, why not just pass out warrants for free? -- ex"
Not certain I agree with this in all cases, but I may be understanding something fundamental.
Let's say somebody like Neil Woodford has 50 million shares in a company, and he is getting close to controlling the company. This is just a hypothetical. All of a sudden he is stopped from investing more for a while. The company has knowledge, so they can't buy, but they and friendlies like Cognate can accumulate through debt financing. The cheaper the shares, and the more shares they obtain, the more they can regain control of the company and dilute NW. Thus, let's say a buyout occurs thereafter. At one time, NW would have owned let's say 1/4 of all securities and NWBO would have been in the same boat. After all the debt financing with cheap shares, oh and bonus options, etc, Neil is back down below 5% ownership whereas, let's say Cogante, Toucan, NWBO management, and a few other friends are combined well above 50%. So the party that "sells" the warrants, really helps themselves eventually?
Not certain I agree with this in all cases, but I may be understanding something fundamental.
Let's say somebody like Neil Woodford has 50 million shares in a company, and he is getting close to controlling the company. This is just a hypothetical. All of a sudden he is stopped from investing more for a while. The company has knowledge, so they can't buy, but they and friendlies like Cognate can accumulate through debt financing. The cheaper the shares, and the more shares they obtain, the more they can regain control of the company and dilute NW. Thus, let's say a buyout occurs thereafter. At one time, NW would have owned let's say 1/4 of all securities and NWBO would have been in the same boat. After all the debt financing with cheap shares, oh and bonus options, etc, Neil is back down below 5% ownership whereas, let's say Cogante, Toucan, NWBO management, and a few other friends are combined well above 50%. So the party that "sells" the warrants, really helps themselves eventually?
Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
